서울대학교 중앙도서관
S-Space 소개
My S-Space
로그인이 필요합니다.
Login

S-Space

Browse

Author

Jump to a point in the index
Or type in a year

  • Sort by
  • In order
  • Results/Page
  • Authors/record

Showing results 1 to 26 of 26

Issue DateTitle / Author(s) / CitationFileAltmetrics
2003-01
Induction chemotherapy followed by radiotherapy in the treatment of anal cancer
DOI
2011-03
Therapeutic plasma exchange in patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: The 10-year experience of a single center
DOI
2011-08
Clinical dissection of multicentric Castleman disease
DOI
2014-06
Risk factors and prognostic impact of venous thromboembolism in Asian patients with non-small cell lung cancer
view fileDOI
2015-10
Cisplatin-Based Chemotherapy Is a Strong Risk Factor for Thromboembolic Events in Small-Cell Lung Cancer

Lee, Yun-Gyoo; Lee, Eunyoung; Kim, Inho; Lee, Keun-Wook; Kim, Tae Min; Lee, Se-Hoon; Kim, Dong-Wan; Heo, Dae Seog

Cancer Research and Treatment, Vol.47 No.4, pp.670-675

view fileDOI
2015-12
Varicella-zoster virus-specific cell-mediated immunity and herpes zoster development in multiple myeloma patients receiving bortezomib- or thalidomide-based chemotherapy
DOI
2016-07
Effectiveness of increasing the frequency of posaconazole syrup administration to achieve optimal plasma concentrations in patients with haematological malignancy
DOI
2017-01
The limited role of serum galactomannan assay in screening for invasive pulmonary aspergillosis in allogeneic stem cell transplantation recipients on micafungin prophylaxis: a retrospective study
DOI
2017-06
Comparison of Plasma Concentrations of Posaconazole with the Oral Suspension and Tablet in Korean Patients with Hematologic Malignancies
DOI
2018-02
Early therapeutic drug monitoring of posaconazole oral suspension in patients with hematologic malignancies
DOI
2018-07
The genetic polymorphism UGT1A4*3 is associated with low posaconazole plasma concentrations in hematological malignancy patients receiving the oral suspension
DOI
2020-01
Strong association between herpes simplex virus-1 and chemotherapy-induced oral mucositis in patients with hematologic malignancies
view fileDOI
2020-02
Prospective evaluation of clinical symptoms of chemotherapy-induced oral mucositis in adult patients with acute leukemia: A preliminary study

Lee, Yeon-Hee; Hong, Junshik; Kim, Inho; Choi, Youngnim; Park, Hee-Kyung

Clinical and Experimental Dental Research, Vol.6 No.1, pp.90-99

DOI
2020-03
Limited Positive Predictive Value of β-D-Glucan in Hematologic Patients Receiving Antimold Prophylaxis
DOI
2020-04
Association of HSV-1 and Reduced Oral Bacteriota Diversity with Chemotherapy-Induced Oral Mucositis in Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation
DOI
2020-06
Risk factors for and clinical outcomes of carbapenem non-susceptible gram negative bacilli bacteremia in patients with acute myelogenous leukemia
DOI
2020-06
Risk factors for and clinical outcomes of carbapenem non-susceptible gram negative bacilli bacteremia in patients with acute myelogenous leukemia
view filelink
2021-01
Immunogenicity and safety of a live herpes zoster vaccine in hematopoietic stem cell transplant recipients
DOI
2021-11
Incidence of invasive fungal infection in acute lymphoblastic and acute myelogenous leukemia in the era of antimold prophylaxis
DOI
2022-01
Cyclophosphamide addition to pomalidomide/dexamethasone is not necessarily associated with universal benefits in RRMM
DOI
2022-06
Safety and efficacy of nilotinib in adult patients with chronic myeloid leukemia: a post-marketing surveillance study in Korea
DOI
2022-07
Effectiveness of antimicrobial stewardship programmes based on rapid antibiotic susceptibility testing of haematological patients having high-risk factors for bacteraemia-related mortality: a post-hoc analysis of a randomised controlled trial

Kim, Jeong-Han; Kim, Taek Soo; Chang, Euijin; Kang, Chang Kyung; Choe, Pyoeng Gyun; Kim, Nam Joong; Oh, Myoung-don; Park, Wan Beom; Kim, Inho

International Journal of Antimicrobial Agents, Vol.60 No.1, p. 106604

DOI
2022-07
Long-term follow-up results of cytarabine-containing chemotherapy for acute promyelocytic leukemia
DOI
2022-07
Characteristics of Sweet syndrome in patients with or without malignancy
DOI
2022-10
AML-119 The Impact of Post-Remission Granulocyte Colony-Stimulating Factor (G-CSF) Use (G-CSFu) in the Phase 3 Studies of Venetoclax (Ven) Combination Treatments in Patients (Pts) With Newly Diagnosed Acute Myeloid Leukemia (AML)
DOI
2023-10
Empirical vs pre-emptive broad-spectrum antifungal therapy for acute myelogenous leukaemia in the era of antimould prophylaxis
DOI
1